Company news
Abbott India Limited news in 2026
Abbott India Limited's news releases, calls and decks from 2026, newest first.
₹656 Dividend Bonanza: 71,000 retail shareholders of this MNC drugmaker set for their highest payout
May 11, 2026
ABBOTINDIA: Revenue and profit rose year-over-year, with higher dividends and an unmodified audit opinion
May 11, 2026
JPMorgan downgrades this drugmaker, cuts price target by 19% citing growth challenges
April 15, 2026
Abbott India to sell Novo Nordisk’s semaglutide, weight-loss drug behind Ozempic
February 27, 2026
ABBOTINDIA: Quarterly profit and revenue increased year-over-year, with new labour codes impacting costs
February 12, 2026
Abbott India shares decline 0.73% amid volume surge
February 10, 2026